Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The second generation CA 125 assays

P Kenemans1, A A Verstraeten, G J van Kamp

  • 1Department of Obstetrics and Gynaecology, Free University Hospital, Amsterdam, The Netherlands.

Annals of Medicine
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy.

Climacteric : the journal of the International Menopause Society·2011
Same author

Therapeutic options for postmenopausal female sexual dysfunction.

Climacteric : the journal of the International Menopause Society·2009
Same author

Oncogenic pathways in hereditary and sporadic breast cancer.

Maturitas·2009
Same author

Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test.

Climacteric : the journal of the International Menopause Society·2008
Same author

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

Breast (Edinburgh, Scotland)·2007
Same author

Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.

Immunological investigations·2007
Same journal

Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

Annals of medicine·2026
Same journal

Postoperative outcomes of on- vs off-pump CABG in patients with HFrEF: a nationwide cohort study in Taiwan.

Annals of medicine·2026
Same journal

Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function.

Annals of medicine·2026
Same journal

Association of neutrophil percentage-to-albumin ratio with sepsis in infant.

Annals of medicine·2026
Same journal

Enhancing Hemoglobin Bart's hydrops fetalis syndrome prevention: a single-tube multiplex real-time PCR assay for the comprehensive detection of four significant α<sup>0</sup>-thalassemia deletions (--<sup>SEA</sup>, --<sup>THAI</sup>, --<sup>CR</sup>, and --<sup>SA</sup>) found in Thailand.

Annals of medicine·2026
Same journal

Association of non-insulin-based insulin resistance indices with the risk of aortic stenosis progression in patients with mild or moderate aortic stenosis.

Annals of medicine·2026
See all related articles

New CA 125 II assays offer superior performance for monitoring ovarian cancer patients. These advanced tests show high correlation with original assays, aiding treatment and recurrence detection.

Area of Science:

  • Clinical chemistry
  • Oncology
  • Immunodiagnostics

Background:

  • CA 125 serum test is crucial for ovarian cancer management, including treatment monitoring, outcome prediction, and recurrence detection.
  • Second-generation CA 125 assays (Centocor CA 125 II, Boehringer Mannheim Enzymun CA 125 II, BYK Liamat CA 125 II) utilize advanced assay technology.
  • These new assays are poised to supersede the original CA 125 assays.

Purpose of the Study:

  • To evaluate the analytical performance and clinical correlation of new second-generation CA 125 II assays.
  • To compare the performance of Centocor CA 125 II, Enzymun CA 125 II, and BYK Liamat CA 125 II against the original CA 125 IRMA and Abbot IMx assays.

Main Methods:

  • Utilized one-step heterologous double-determinant solid phase assays with specific capture and tracer antibodies.

Related Experiment Videos

  • Performed linear regression analysis on CA 125 levels from ovarian cancer patients.
  • Included Abbot IMx CA 125 assay for comparative analysis.

    • Main Results:

    • All three new CA 125 II assays demonstrated highly similar CA 125 distribution patterns.
    • Strong linear correlations were observed between the new assays and the original CA 125 IRMA (r values ranging from 0.8717 to 0.8930, P < 0.0001).
    • The new assays exhibited superior analytical performance compared to original assays.

    Conclusions:

    • The new generation CA 125 II assays possess superior analytical performance.
    • These assays show a high qualitative and quantitative correlation with the original CA 125 IRMA.
    • The advanced CA 125 II assays are expected to become the standard for ovarian cancer patient management.